|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stem Cell Genetics and Genomics |
1 Research Center Reproduction and Genetics, University Hospital and Medical School of the 'Vrije Universiteit Brussel' (Free University of Brussels), Brussels, Belgium
2 Research Center Reproduction and Genetics, University Hospital and Medical School of the 'Vrije Universiteit Brussel' (Free University of Brussels), Brussels, Belgium; Center for Medical Genetics, University Hospital and Medical School of the 'Vrije Universiteit Brussel' (Free University of Brussels), Brussels, Belgium
3 Research Center Reproduction and Genetics, University Hospital and Medical School of the 'Vrije Universiteit Brussel' (Free University of Brussels), Brussels, Belgium; Center for Reproductive Medicine, University Hospital and Medical School of the 'Vrije Universiteit Brussel' (Free University of Brussels), Brussels, Belgium
* To whom correspondence should be addressed. E-mail: gcauffma{at}az.vub.ac.be.
| Abstract |
|---|
The contribution of the POU domain, class 5, transcription factor 1 (POU5F1) in maintaining totipotency in human embryonic stem (hES) cells has been repeatedly proven. In humans, two isoforms are encoded: POU5F1_iA and POU5F1_iB. So far, no discrimination has been made between the isoforms in POU5F1 studies and it is unknown which isoform contributes to the undifferentiated phenotype. Using immunocytochemistry, expression of POU5F1_iA and POU5F1_iB was examined in hES cells and all stages of human preimplantation development to look for differences in expression, biological activity and relation to totipotency. POU5F1_iA and POU5F1_iB displayed different temporal and spatial expression patterns. During human preimplantation development, a significant POU5F1_iA expression was seen in all nuclei of compacted embryos and blastocysts and a clear POU5F1_iB expression was detected from the four-cell stage onwards in the cytoplasm of all cells. The cytoplasmic localization might imply no or other biological functions beyond transcription activation for POU5F1_iB. The stemness properties of POU5F1 can be assigned to POU5F1_iA because hES cells expressed POU5F1_iA but not POU5F1_iB. However, POU5F1_iA is not the appropriate marker to identify totipotent cells because POU5F1_iA was also expressed in the non-totipotent trophectoderm and was not expressed in zygotes and early cleavage stage embryos, which are assumed to be totipotent. POU5F1_iA's expression pattern may suggest that POU5F1_iA alone cannot sustain totipotency and that co-expression with other stemness factors might be the key to totipotency.
Key Words. POU5F1, OCT-4, totipotency, stem cell marker, human embryonic stem cells, human preimplantation embryos
This article has been cited by other articles:
![]() |
G. Cauffman, M. De Rycke, K. Sermon, I. Liebaers, and H. Van de Velde Markers that define stemness in ESC are unable to identify the totipotent cells in human preimplantation embryos Hum. Reprod., January 1, 2009; 24(1): 63 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Atlasi, S. J. Mowla, S. A.M. Ziaee, P. J. Gokhale, and P. W. Andrews OCT4 Spliced Variants Are Differentially Expressed in Human Pluripotent and Nonpluripotent Cells Stem Cells, December 1, 2008; 26(12): 3068 - 3074. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kaltz, A. Funari, S. Hippauf, B. Delorme, D. Noel, M. Riminucci, V. R. Jacobs, T. Haupl, C. Jorgensen, P. Charbord, et al. In Vivo Osteoprogenitor Potency of Human Stromal Cells from Different Tissues Does Not Correlate with Expression of POU5F1 or Its Pseudogenes Stem Cells, September 1, 2008; 26(9): 2419 - 2424. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Van de Velde, G. Cauffman, H. Tournaye, P. Devroey, and I. Liebaers The four blastomeres of a 4-cell stage human embryo are able to develop individually into blastocysts with inner cell mass and trophectoderm Hum. Reprod., August 1, 2008; 23(8): 1742 - 1747. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ullmann, C. Gilles, M. De Rycke, H. Van de Velde, K. Sermon, and I. Liebaers GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions Mol. Hum. Reprod., March 1, 2008; 14(3): 169 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kotoula, S. I. Papamichos, and A. F. Lambropoulos Revisiting OCT4 Expression in Peripheral Blood Mononuclear Cells Stem Cells, January 1, 2008; 26(1): 290 - 291. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
